| 1 | Receive the Annual Report | Abstain |
| 2 | Approve the Dividend | For |
| 3 | Re-appoint PwC as the Auditors | Oppose |
| 4 | Allow the Board to Determine the Auditor's Remuneration | For |
| 5 | Elect Laura Balan - Non-Executive Director | For |
| 6 | Elect Victoria Hull - Non-Executive Director | For |
| 7 | Elect Deneen Vojta - Non-Executive Director | For |
| 8 | Re-elect Said Darwazah - Chair & Chief Executive | Oppose |
| 9 | Re-elect Mazen Darwazah - Vice Chair (Executive) | Oppose |
| 10 | Re-elect Patrick Butler - Non-Executive Director | For |
| 11 | Re-elect Ali Al-Husry - Non-Executive Director | For |
| 12 | Re-elect John Castellani - Non-Executive Director | For |
| 13 | Re-elect Nina Henderson - Designated Non-Executive | Oppose |
| 14 | Re-elect Cynthia Flowers - Non-Executive Director | For |
| 15 | Re-elect Douglas Hurt - Non-Executive Director | For |
| 16 | Approve the Remuneration Report | Oppose |
| 17 | Approve Remuneration Policy | Oppose |
| 18 | Issue Shares with Pre-emption Rights | For |
| 19 | Approve the Hikma Pharmaceuticals PLC Long-Term Incentive Plan 2023 | Oppose |
| 20 | Approve Hikma Pharmaceuticals PLC Deferred Bonus Plan 2023 | Oppose |
| 21 | Issue Shares for Cash | Oppose |
| 22 | Issue Shares for Cash for the Purpose of Financing an Acquisition or Other Capital Investment | Oppose |
| 23 | Authorise Share Repurchase | Oppose |
| 24 | Meeting Notification-related Proposal | Oppose |